Early research (Phase 1)Study completedNCT01536366What this trial is testingEffect of BIA 9-1067 on the Pharmacokinetics of RepaglinideWho this might be right forParkinson Disease Bial - Portela C S.A. 27
Early research (Phase 1)UnknownNCT04664725What this trial is testingDrug-drug Interaction of SHR3680 With Repaglinide and BupropionWho this might be right forProstate Cancer Patients Jiangsu HengRui Medicine Co., Ltd. 18
Early research (Phase 1)Study completedNCT02128321What this trial is testingEvaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and CaffeineWho this might be right forPharmacokinetics of RepaglinidePharmacokinetics of CaffeineHealthy Subjects Astellas Pharma Global Development, Inc. 24
Early research (Phase 1)Study completedNCT01489644What this trial is testingSingle Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy VolunteersWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 62
Early research (Phase 1)Study completedNCT06948747What this trial is testingInvestigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy ParticipantsWho this might be right forHealthy Participants AstraZeneca 49
Early research (Phase 1)Not Yet RecruitingNCT07372625What this trial is testingInvestigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.Who this might be right forTP53 Y220C MutationAdvanced Solid Tumors PMV Pharmaceuticals, Inc 14
Early research (Phase 1)Study completedNCT07235748What this trial is testingDrug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult ParticipantsWho this might be right forHealthy Adult Participants Institut de Recherches Internationales Servier (I.R.I.S.) 28
Early research (Phase 1)Study completedNCT05236530What this trial is testingDrug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and DolutegravirWho this might be right forMalaria Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT04530981What this trial is testingA Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GISTWho this might be right forGIST - Gastrointestinal Stromal Tumor Deciphera Pharmaceuticals, LLC 13
Early research (Phase 1)Study completedNCT06165146What this trial is testingThe Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Substrate) in Healthy ParticipantsWho this might be right forHealthy Eli Lilly and Company 16
Early research (Phase 1)Not Yet RecruitingNCT07340190What this trial is testingA Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignancies Novartis Pharmaceuticals 24
Early research (Phase 1)Study completedNCT04718740What this trial is testingA Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian CancerWho this might be right forRecurrent Ovarian Cancer Jiangsu HengRui Medicine Co., Ltd. 33
Early research (Phase 1)Study completedNCT05469113What this trial is testingEffects of Selpercatinib (LY3527723) on Repaglinide in Healthy ParticipantsWho this might be right forHealthy Eli Lilly and Company 16
Early research (Phase 1)Study completedNCT06503679What this trial is testingA Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy ParticipantsWho this might be right forHealthy DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 49
Early research (Phase 1)Active Not RecruitingNCT07065058What this trial is testingA Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese SubjectsWho this might be right forObesity &Amp; Overweight Vincentage Pharma Co., Ltd 24
Early research (Phase 1)Not Yet RecruitingNCT06601517What this trial is testingA Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Who this might be right forHealthy Adult SubjectOverweight Subject Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Study completedNCT01797198What this trial is testingAssess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy SubjectsWho this might be right forDrug-Drug Interaction (DDI)Healthy Subjects Astellas Pharma Europe B.V. 48
Early research (Phase 1)Study completedNCT01490658What this trial is testingSingle Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy VolunteersWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 93
Early research (Phase 1)Study completedNCT02305901What this trial is testingThe Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 18
Early research (Phase 1)Study completedNCT00959101What this trial is testingComparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy VolunteersWho this might be right forDiabetesHealthy Novo Nordisk A/S 42